| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $822.5M | — | +7.3% |
| Cost of Revenue | $151.8M | — | +8.0% |
| Gross Profit | $670.7M | — | +7.1% |
| R&D Expense | $141.2M | — | +8.2% |
| SG&A Expense | $90.6M | — | +24.1% |
| Operating Income | $214.2M | — | +4.4% |
| Pre-tax Income | $222.9M | — | +6.6% |
| Income Tax | $42.9M | — | +0.6% |
| Net Income | $180.1M | — | +8.2% |
| EPS (Basic) | $3.12 | — | +9.5% |
| EPS (Diluted) | $3.10 | — | +9.9% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.20B | -10.8% | +4.2% |
| Short-term Investments | $0 | — | — |
| Accounts Receivable | $493.6M | +19.1% | +1.8% |
| Inventory | $79.9M | +3.5% | +9.1% |
| Current Assets | $2.52B | -0.1% | +7.4% |
| Total Assets | $6.29B | -0.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $159.2M | — | -21.5% |
| Capital Expenditures | $9.7M | — | +20.4% |
| Investing Cash Flow | -$10.6M | — | -5.9% |
| Financing Cash Flow | -$293.0M | — | -155.5% |
| Free Cash Flow | $149.5M | — | -23.2% |
| +6.6% |
| Current Liabilities | $1.62B | +0.4% | +2.0% |
| Stockholders' Equity | $3.54B | -1.5% | +9.3% |